EnGene Therapeutics says FDA pre-BLA meeting on track for 4Q
EnGene Therapeutics reports its FDA pre-Biologics License Application meeting remains on track for 4Q.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.